ProMIS Neurosciences Inc PMN

Gbathat the second Boston Group mole is surfacing!!

[FarmerBetty]

The PR by Promisneurosciences in August/21 which says "we expect our cash is sufficient to finance the company's operations for the next twelve months". No different projects identified for cash moving forward with an IND filing for AD. Suddenly Ocober/21 another PP to the Boston group reportedly needed for advancing the IND filing?? Shortly after Gbathat blogged that Acumen is funded through 2024. "but i think the Boston group will buy in at $5/share to get them there". Meaning Promis!!

Exactly at that price of $5 on the Nasdaq, no news for months, low low volume naturally perfectly executed by the Boston group Mike Gordon and Jeremy Sclar amongst others. Acumen a one trick pony with AD raised millions at a much higher share price.  Promis has AD, ALS and PD porfolio's on the go.  Let's see what materializes?? Is the Boston fix in ?? or is something else happening ??

[Gbathat]

$5 share price is what is needed to stay listed on Nasdaq.  So yes, the Boston group would probably have a strong interest in not letting the PPS fall below $5. As posted multiple times, if you subtract the cash holdings of ABOS from their market cap, the valuation is similar to PMN, in my opinion. Since ABOS is about a year ahead of PMN, PMN might actually be favored a bit. And I think